Immunohistochemical and t-cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory celiac disease

Journal of Clinical Gastroenterology

Volumn 47, Issue 7, 2013, Pages 593-601

  Arguelles Grande, Carolina ^a,b   Brar, Pardeep ^a,b   Green, Peter H R ^a,b   Bhagat, Govind ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Departments of Medicine   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

intraepithelial lymphocytes; morbidity; mortality; phenotype; refractory celiac disease; T cell receptor gene rearrangement

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CELIAC DISEASE; CHROMOSOME ABERRATION; CLONAL VARIATION; DISEASE CLASSIFICATION; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRAEPITHELIAL LYMPHOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY CELIAC DISEASE; SEROLOGY; SEX DIFFERENCE; SURVIVAL RATE; T LYMPHOCYTE RECEPTOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD8; CELIAC DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ANTIGEN, T-CELL; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84880706625     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31828a3c44     Document Type: Article

References (28)

1. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:413-424.
2. Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136:81-90.
3. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated t-cell lymphoma. French coeliac disease study group. Lancet. 2000;356:203-208.
4. Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther. 2003;18:487-494.
5. Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. When is a coeliac a coeliac? Eur J Gastroenterol Hepatol. 2001;13:1123-1128.
6. Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998;114:471-481.
7. de Mascarel A, Belleannee G, Stanislas S, et al. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable cd8 phenotype. Am J Surg Pathol. 2008;32:744-751.
8. Daum S, Weiss D, Hummel M, et al. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut. 2001;49:804-812.
9. van de Water JM, Cillessen SA, Visser OJ, et al. Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol. 2010;24:43-56.
10. Brar P, Lee S, Lewis S, et al. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol. 2007;102:2265-2269.
11. Al-Toma A, Goerres MS, Meijer JW, et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol. 2006;4:1322-1327; quiz 1300.
12. Al-toma A, Visser OJ, van Roessel HM, et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant t cells. Blood. 2007;109:2243-2249.
13. Rubio-Tapia A, Kelly DG, Lahr BD, et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology. 2009;136:99-107; quiz 352-103.
14. Maurino E, Niveloni S, Chernavsky AC, et al. Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution. Acta Gastroenterol Latinoam. 2006;36:10-22.
15. Daum S, Ipczynski R, Schumann M, et al. High rates of complications and substantial mortality in both types of refractory sprue. Eur J Gastroenterol Hepatol. 2009;21:66-70.
16. Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated t-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56:1373-1378.
17. Carbonnel F, Grollet-Bioul L, Brouet JC, et al. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood. 1998;92:3879-3886.
18. Roshan B, Leffler DA, Jamma S, et al. The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol. 2011;106:923-928.
19. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-1194.
20. Patey-Mariaud De Serre N, Cellier C, Jabri B, et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology. 2000;37:70-77.
21. Bottaro M, Berti E, Biondi A, et al. Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood. 1994;83:3271-3278.
22. O'Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671-680.
23. Ludvigsson JF, Leffler DA, Bai JC, et al. The oslo definitions for coeliac disease and related terms. Gut. 2013;62:43-52.
24. Savilahti E, Ormala T, Arato A, et al. Density of gamma/delta + T cells in the jejunal epithelium of patients with coeliac disease and dermatitis herpetiformis is increased with age. Clin Exp Immunol. 1997;109:464-467.
25. Maki M, Holm K, Collin P, et al. Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut. 1991;32:1412-1414.
26. Iltanen S, Holm K, Ashorn M, et al. Changing jejunal gamma delta T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol. 1999;117:51-55.
27. Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol. 2002;118:459-463.
28. Leon F. Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J Immunol Methods. 2011;363: 177-186.